Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9195044 | 0.89 | RAB9A (0.33) | CYP2C19NPC1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL7450264 | 0.86 | CYP2C19 (0.34) | CYP2C19RAB9A | |
| SCHEMBL7443696 | 0.82 | NPC1 (0.32) | NPC1RAB9ASMN1; SMN2ALDH1A1GLA | |
| SCHEMBL7483351 | 0.78 | ALDH1A1 (0.34) | ALDH1A1TSHR | |
| SCHEMBL9196771 | 0.78 | NQO1 (0.31) | — | |
| SCHEMBL9197378 | 0.77 | ICMT (0.33) | TSHR | |
| SCHEMBL7444806 | 0.76 | — | — | |
| SCHEMBL9199709 | 0.75 | MEN1 (0.33) | NPC1RAB9AALDH1A1 | |
| SCHEMBL7443077 | 0.75 | CYP2C9 (0.37) | SMN1; SMN2GLA | |
| SCHEMBL7440515 | 0.74 | NQO1 (0.40) | CYP2C19NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0668860-A1 | PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES | PHARMACIA & UPJOHN COMPANY (US) | 1995-08-30 | — | — | EP | claimed |